Regadenoson Injection
Product Images NDC 43598-616

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 43598-616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) prefilled syringe label by Dr. Reddy's Laboratories Inc. This single bolus dose intravenous injection is a pharmacologic stress agent for diagnostic use. The label includes storage instructions, ingredient information, barcodes, and usage guidelines emphasizing sterile, nonpyrogenic conditions and immediate administration within 10 seconds.*

FDA Label Image

Pfs (Pfs)

Label for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) intravenous injection by Dr. Reddy's Laboratories Inc. The label indicates it is for pharmacologic stress only, single dose vial, Rx only, distributed by Dr. Reddy's Laboratories in Princeton, NJ, made in India.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Regadenoson showing its molecular connectivity including fused rings, nitrogen atoms, and hydroxyl groups. The structure includes a ribose sugar moiety linked to a purine base with additional functional groups present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.